Sevion Therapeutics, Inc. — Form D

Sevion Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-09. The offering totals $11.5M, of which $11.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
John N BracaDirectorElko, NV
Christopher N ForbesDirectorNew Brunswick, NJ
Warren J IsabelleDirectorNew Brunswick, NJ
Thomas C QuickDirectorNew Brunswick, NJ
David C RectorDirectorNew Brunswick, NJ
Rudolf C StalderDirectorNew Brunswick, NJ
John E ThompsonDirectorNew Brunswick, NJ
Jack Van HulstDirectorSan Francisco, CA
Joel P BrooksExecutive OfficerNew Brunswick, NJ
Richard J DonderoExecutive OfficerNew Brunswick, NJ
John E ThompsonExecutive OfficerNew Brunswick, NJ
Jack Van HulstExecutive OfficerSan Francisco, CA
Vaughn SmiderDirectorSan Diego, CA
Vaughn SmiderExecutive OfficerSan Diego, CA
David RectorDirectorElko, NV
David RectorExecutive OfficerElko, NV
Miguel A de los RiosExecutive OfficerSan Diego, CA
John W BracaDirectorSan Diego, CA
Phillip W FrostDirectorSan Diego, CA
Joel BrooksExecutive OfficerSan Diego, CA
Steven W RubinDirectorSan Diego, CA
Harlan W WaksalDirectorSan Diego, CA
James A GrazianoExecutive OfficerSan Diego, CA

Other filings by this issuer (1)

FiledFormOfferingSold
2015-05-15D$10.0M$3.0M

More